Provided by the Annenberg Center for Health Sciences at Eisenhower
Commercial Supporter
This activity is supported by educational grants from AstraZeneca and GlaxoSmithKline.
Program Description
Approximately 12 million children and adults in the U.S. have inadequately controlled asthma, many with severe asthma. Reynold Panettieri, Jr., MD and Nicola Hanania, MD, MS, discuss the importance of and how to differentiate severe from uncontrolled asthma.
Content Areas: Definition and features, GINA 2018, Pathophysiology, Phenotypes and biomarkers, Shared decision-making, and Targeted biologics
Intended Audience
This activity was developed for pulmonologists, allergists, and other clinicians involved in the management of severe asthma.
Educational Objectives
Upon completion of this activity, participants will be able to:
Describe current evidence for the use of biological-based therapies for the treatment of severe asthma
Differentiate biological-based therapies for the treatment of severe asthma based on patient- and treatment-related factors
Utilize genetic information to select the appropriate biological-based therapy for a patient with severe asthma
Apply updated guidance to optimally utilize biological-based therapy in patients with severe asthma
Conflict Of Interest Disclosure Policy
It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.
The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.
In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:
Faculty
Nicola A. Hanania, MD, MS Associate Professor of Medicine Section of Pulmonary and Critical Care Medicine Director, American Lung Association Airways Clinical Research Center Baylor College of Medicine Houston, Texas
Dr. Hanania discloses the following: Research Support: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline Consultant: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Sanofi/Regeneron Speaker Bureau: AstraZeneca
Reynold A. Panettieri, Jr, MD Vice Chancellor for Translational Medicine and Science Director, Rutgers Institute for Translational Medicine and Science Robert Wood Johnson Medical School New Brunswick, New Jersey
Additional content planners Eugene Cullen, MD (peer reviewer) has nothing to disclose. Gregory Scott, PharmD, RPh (lead nurse planner) has nothing to disclose.
Annenberg Center for Health Sciences Charles Willis, Director of Continuing Education, consults for Pfizer, Inc.
All the staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.
Credit
1.50
Type
AMA PRA Category 1 Credit(s)TM
Accreditation Statement
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
The faculty for this activity have disclosed that there will be no discussion about the use of products for non-FDA approved applications.
Disclaimer
The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.
Instructions
This activity is an online enduring material. Successful completion is achieved by reading and/or viewing the material, reflecting on its implications for your practice, and completing the assessment component.
Please note: The content of this activity is housed on the website of our educational partner, Annenberg Center for Health Sciences at Eisenhower, and requires you to leave myCME and register on the Annenberg website.
Your certificate will be saved on the Annenberg website only and cannot be accessed in your myCME CME History. Please go to https://education.annenberg.net and sign in to access your certificate in the future.
Contact Information
For help or questions about this Internet activity, please contact Annenberg Continuing Education: ce@annenberg.net Annenberg Center for Health Sciences 39000 Bob Hope Drive Dinah Shore Building Rancho Mirage, CA 92270 Phone: 760-773-4500 Fax: 760-773-4513 8 AM – 5 PM, Pacific Time, Monday – Friday
Privacy Policy
Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at http://www.annenberg.net/privacy-policy/
